SLDB
Solid Biosciences Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.25
−1.63%Leverage
- Debt / equity
- 0.05x
- Net debt / equity
- -0.37x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.10x
- Net debt / EBITDA
- 0.68x
Liquidity & coverage
- Current ratio
- 13.82x
- Quick ratio
- 13.82x
- Cash ratio
- 13.21x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $366.5M
Cash & dividend
- FCF / debt
- -9.32x
- Cash flow / debt
- -9.27x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026